Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney H Falk

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Journal of the American College of Cardiology|July 31, 2007
Ethnic disparity in intracranial hemorrhage among anticoagulated patients with atrial fibrillation: an answer in search of a question?Rodney H Falk
The New England Journal of Medicine|December 6, 2002
Management of atrial fibrillation--radical reform or modest modification?Rodney H Falk
Circulation|August 31, 2011
Cardiac amyloidosis: a treatable disease, often overlookedRodney H Falk
Circulation|June 16, 2005
Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillationRodney H Falk
JACC. Case Reports|May 14, 2026
Technetium Pyrophosphate Blood Pool Uptake Mistaken for Myocardial Uptake in Light-Chain Amyloidosis: A Dangerous MisinterpretationRodney H Falk
The American Journal of Geriatric Cardiology|November 6, 2002
Ventricular rate control in the elderly: is digoxin enough?Rodney H Falk
The New England Journal of Medicine|March 23, 2012
Dronedarone in high-risk permanent atrial fibrillationRodney H Falk
Circulation|November 16, 2011
Letter by Falk regarding article, "An unusual heart failure: cardiac amyloidosis due to light chain myeloma"Rodney H Falk
Journal of the American College of Cardiology|August 15, 2006
Atrial fibrillation or sinus rhythm? Controversy and contradiction in quality of life outcomesRodney H Falk
European Heart Journal|January 23, 2019
Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?Rodney H Falk
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Journal of the American College of Cardiology|July 31, 2007
Ethnic disparity in intracranial hemorrhage among anticoagulated patients with atrial fibrillation: an answer in search of a question?Rodney H Falk
The New England Journal of Medicine|December 6, 2002
Management of atrial fibrillation--radical reform or modest modification?Rodney H Falk
Circulation|August 31, 2011
Cardiac amyloidosis: a treatable disease, often overlookedRodney H Falk
Circulation|June 16, 2005
Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillationRodney H Falk
JACC. Case Reports|May 14, 2026
Technetium Pyrophosphate Blood Pool Uptake Mistaken for Myocardial Uptake in Light-Chain Amyloidosis: A Dangerous MisinterpretationRodney H Falk
The American Journal of Geriatric Cardiology|November 6, 2002
Ventricular rate control in the elderly: is digoxin enough?Rodney H Falk
The New England Journal of Medicine|March 23, 2012
Dronedarone in high-risk permanent atrial fibrillationRodney H Falk
Circulation|November 16, 2011
Letter by Falk regarding article, "An unusual heart failure: cardiac amyloidosis due to light chain myeloma"Rodney H Falk
Journal of the American College of Cardiology|August 15, 2006
Atrial fibrillation or sinus rhythm? Controversy and contradiction in quality of life outcomesRodney H Falk
European Heart Journal|January 23, 2019
Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?Rodney H Falk
Pageof 16